Oral curcumin for radiation dermatitis: a URCC NCORP study of 686 breast cancer patients
Despite advances in medical technology, radiation dermatitis occurs in 95% of patients receiving radiation therapy (RT) for cancer. Currently, there is no standard and effective treatment for the prevention or control of radiation dermatitis. The goal of the study was to determine the efficacy of oral curcumin, one of the biologically active components in turmeric, at reducing radiation dermatitis severity (RDS) at the end of RT, using the RDS scale, compared to placebo.
This was a multisite, randomized, double-blinded, placebo-controlled trial of 686 breast cancer patients. Patients took four 500-mg capsules of placebo or curcumin three times daily throughout their prescribed course of RT until 1 week post-RT.
A total of 686 patients were included in the final analyses (87.5% white females, mean age = 58). Linear mixed-model analyses demonstrated that curcumin did not reduce radiation dermatitis severity at the end of RT compared to placebo (B (95% CI) = 0.044 (− 0.101, 0.188), p = 0.552). Fewer curcumin patients with RDS > 3.0 suggested a trend toward reduced severity (7.4 vs. 12.9%, p = 0.082). Patient-reported changes in pain, symptoms, and quality of life were not statistically significant between arms.
Oral curcumin did not significantly reduce radiation dermatitis severity compared to placebo. The skin rating variation and broad eligibility criteria could not account for the undetectable therapeutic effect. An objective measure for radiation dermatitis severity and further exploration for an effective treatment for radiation dermatitis is warranted.
KeywordsRadiation therapy Dermatitis Curcumin Cancer Skin
This study was supported by the FDA IND 75,444, the National Institutes of Health PHS grant R25CA102618 (Cancer Control research), and UG1CA189961 (NCORP).
Compliance with ethical standards
Conflict of interest
None of the authors have any conflicts of interest to disclose. I (JRW) have full control of all primary data and agree to allow the journal to review the data if requested.
- 5.Di Franco R, Calvanese M, Murino P, Manzo R, Guida C, Di Gennaro D, Anania C, Ravo V (2012) Skin toxicity from external beam radiation therapy in breast cancer patients: protective effects of resveratrol, lycopene, vitamin C and anthocianin (Ixor(R)). Radiat Oncol 7:12CrossRefPubMedPubMedCentralGoogle Scholar
- 10.Robertson C, Robertson AG, Hendry JH, Roberts SA, Slevin NJ, Duncan WB, MacDougall RH, Kerr GR, O'Sullivan B, Keane TJ (1998) Similar decreases in local tumor control are calculated for treatment protraction and for interruptions in the radiotherapy of carcinoma of the larynx in four centers. Int J Radiat Oncol Biol Phys 40:319–329CrossRefPubMedGoogle Scholar
- 12.Prasad S, Aggarwal BB (2011) Turmeric, the golden spice: from traditional medicine to modern medicine. In: Benzie IFF W-GS (ed) Herbal medicine: biomolecular and clinical aspects. CRC Press/Taylor & FrancisGoogle Scholar
- 22.Okunieff P, Xu J, Hu D, Liu W, Zhang L, Morrow G, Pentland A, Ryan JL, Ding I (2006) Curcumin protects against radiation-induced acute and chronic cutaneous toxicity in mice and decreases mRNA expression of inflammatory and fibrogenic cytokines. Int J Radiat Oncol Biol Phys 65:890–898CrossRefPubMedGoogle Scholar
- 27.Ferreira EB, Vasques CI, Gadia R, Chan RJ, Guerra EN, Mezzomo LA, De Luca Canto G, Dos Reis PE (2017) Topical interventions to prevent acute radiation dermatitis in head and neck cancer patients: a systematic review. Supportive care in cancer: official journal of the multinational association of. Support Care Cancer 25:1001–1011CrossRefPubMedGoogle Scholar
- 28.Liguori V, Guillemin C, Pesce GF, Mirimanoff RO, Bernier J (1997) Double-blind, randomized clinical study comparing hyaluronic acid cream to placebo in patients treated with radiotherapy radiotherapy and oncology: journal of the European Society for Therapeutic. Radiol Oncol 42:155–161CrossRefGoogle Scholar
- 31.Ulff E, Maroti M, Serup J, Nilsson M, Falkmer U (2016) Prophylactic treatment with a potent corticosteroid cream ameliorates radiodermatitis, independent of radiation schedule: A randomized double blinded study. Radiother Oncol: J Eur Soc Therap Radiol OncolGoogle Scholar
- 32.Bhagavathula N, Warner RL, DaSilva M, McClintock SD, Barron A, Aslam MN, Johnson KJ, Varani J (2009) A combination of curcumin and ginger extract improves abrasion wound healing in corticosteroid-impaired hairless rat skin. Wound repair and regeneration: official publication of the wound healing society [and] the European tissue repair. Society 17:360–366Google Scholar
- 33.Fray TR, Watson AL, Croft JM, Baker CD, Bailey J, Sirel N, Tobias A, Markwell PJ (2004) A combination of aloe vera, curcumin, vitamin C, and taurine increases canine fibroblast migration and decreases tritiated water diffusion across canine keratinocytes in vitro. J Nutr 134:2117S–2119SCrossRefPubMedGoogle Scholar
- 35.Sekiguchi K, Kawamori J, Yamauchi H (2017) Breast reconstruction and postmastectomy radiotherapy: complications by type and timing and other problems in radiation oncology. Breast CancerGoogle Scholar
- 36.Gonzalez Sanchis A, Brualla Gonzalez L, Sanchez Carazo JL, Gordo Partearroyo JC, Esteve Martinez A, Vicedo Gonzalez A, Lopez Torrecilla JL (2017) Evaluation of acute skin toxicity in breast radiotherapy with a new quantitative approach radiotherapy and oncology: journal of the European Society for Therapeutic. Radiol Oncol 122:54–59CrossRefGoogle Scholar
- 45.Palatty PL, Azmidah A, Rao S, Jayachander D, Thilakchand KR, Rai MP, Haniadka R, Simon P, Ravi R, Jimmy R, D'Souza PF, Fayad R, Baliga MS (2014) Topical application of a sandal wood oil and turmeric based cream prevents radiodermatitis in head and neck cancer patients undergoing external beam radiotherapy: a pilot study. Br J Radiol 87:20130490CrossRefPubMedPubMedCentralGoogle Scholar